European drug manufacturers under threat from proposed US supply chain bill

The US Pharmaceutical Investment Oversight and Accountability Act and a US Trade Representative investigation threaten Europe's pharmaceutical manufacturing dominance, particularly Germany, by aiming to onshore drug manufacturing and scrutinise drug pricing, potentially leading to tariffs and supply chain shifts.

This Wire brief sits within Fusion42's coverage of Health.